Foghorn Therapeutics Competitors and Similar CompaniesClear all
Foghorn Therapeutics's competitors and similar companies include Nurix Therapeutics, Kymera Therapeutics, Arvinas and Ultivue.
 Foghorn Therapeutics Foghorn Therapeutics is a developer of gene therapies for hematologic cancers and solid tumors. |  Kymera Therapeutics Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases. |  Arvinas Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases. | |||
Founding Date | Founding Date 2016 | Founding Date 2012 | Founding Date 2017 | Founding Date N/A | Founding Date 2015 |
Type | Type Public | Type Public | Type Public | Type Public | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ Cambridge, US | Locations San Francisco, US HQ | Locations Watertown, US HQ Cambridge, US | Locations New Haven, US HQ | Locations Cambridge, US HQ Segrate, IT |
Employees | Employees 1123% decrease | Employees 3344% increase | Employees 207 | Employees 13329% increase | Employees 432% decrease |
Valuation ($) | Valuation ($) 452 m | Valuation ($) N/A | Valuation ($) 3.1 b | Valuation ($) 1.9 b | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $30.9m (FY, 2025) | Revenue (est.) $84m (FY, 2025) | Revenue (est.) $39.2m (FY, 2025) | Revenue (est.) $262.6m (FY, 2025) | Revenue (est.) N/A |
Net income | Net income ($74.4m) (FY, 2025) | Net income ($264.5m) (FY, 2025) | Net income ($311.4m) (FY, 2025) | Net income ($80.8m) (FY, 2025) | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 50m | Total funding raised $ 165.2m | Total funding raised $ 197m | Total funding raised $ 111.6m | Total funding raised $ 57.3m |
For sources of this data, please see the company profile
View Company Profiles
Nurix Therapeutics
HQ
San Francisco, US
Employees
334↑ 4% increase
Nurix Therapeutics is a clinical-stage biopharmaceutical company.
View companyKymera Therapeutics
HQ
Watertown, US
Employees
207
Kymera Therapeutics is a biotechnology company aimed to create medicines for patients with previously untreatable diseases.
View companyArvinas
HQ
New Haven, US
Employees
133↑ 29% increase
Arvinas is a biopharmaceutical company focused on developing protein degradation therapeutics for cancers and other diseases.
View company
Ultivue
HQ
Cambridge, US
Employees
43↓ 2% decrease
Ultivue operates in the biotechnology industry.
View company